Correlation between Anemia and Malaria Infection Severity in Patients with Type 2 Diabetes Mellitus in Nigeria by Atere, Adedeji David et al.
Althea Medical Journal. 2020;7(4)
170     AMJ December 2020
Correlation between Anemia and Malaria Infection Severity in Patients 
with Type 2 Diabetes Mellitus in Nigeria
Adedeji David Atere,1,2 Henry Chijindu Okpoli,2 Kelvin Aimuemwosa Uwumarogie,2 
Adebimpe Iyanuoluwa Moronkeji2
1Department of Medical Laboratory Science, Faculty of Basic Medical Sciences, Adeleke 
University, Ede, Osun State, Nigeria, 2Department of Medical Laboratory Science, Achievers 
University, Owo, Ondo State, Nigeria
Correspondence: Adedeji David Atere, Department of Medical Laboratory Science, Faculty of Basic Medical Sciences, 
Adeleke University, Ede, Nigeria, E-mail: ateread@gmail.com
Introduction
Malaria is the most common vector-borne 
parasitic disease of the globe and still a 
main public health challenge in more than a 
hundred countries across the globe with more 
than 2.5 billion people at the chance, causing 
a few million deaths yearly.1 A recent study 
has shown a correlation between Plasmodium 
infection and blood glucose levels. Plasmodium 
depends exclusively on an exogenous supply of 
glucose for survival due to the inability to store 
energy in form of glycogen.2 On the other end, 
diabetes mellitus (DM) is one of the most well-
known non-transmittable diseases, that has 
an absolute or relative insulin lack.3 Diabetes 
is a degenerative disease characterized via 
disordered metabolism and hyperglycemia 
due to insufficient levels of the hormone 
insulin with or without additional resistance 
of insulin’s impact on many body cells.4 There 
is insulin-dependent diabetes mellitus (IDDM) 
which is generally alluded to as type 1 diabetes, 
and insulin-independent diabetes additionally 
referred to as type 2 diabetes. Type 2 DM is 
found in around 70–90% of diabetic cases 
and normally impacts humans aged 30 years 
and above.5,6 Evidence has clearly stated that 
DM will be pandemic in many developing and 
industrialized nations, attributable to the 
western-style diet.3
In tropical Africa, malaria poses a dangerous 
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Abstract
Background: Malaria and diabetes mellitus are still a significant global public health problem despite 
the phenomenal progresses in clinical sciences related to the diseases. Both anemia and malaria 
parasitemia are common in developing countries. It is therefore important to diagnose and determine 
the correlation between anemia level and malaria infection severity in diabetic patients for better 
management. 
Methods: Patients with diabetes mellitus (DM) infected with malaria were recruited (n=50) as subjects 
and non-diabetic patients were used as control in this study, who were further divided into two sub-
group: non-DM infected with malaria (n=25) and non-DM without malaria parasitemia (n=25). Blood 
sample were collected to examine the fasting blood sugar (FBS) level, packed cell volume (PCV), 
hemoglobin (Hb) level, and malaria parasitemia. Statistical analysis was then performed using ANOVA 
with a p value of less than or equal to 0.05 considered statistically significant.
Results: The parasite density in DM with malaria was significantly lower (p<0.05) than in the non-DM 
with malaria. Interestingly, there was a higher PCV and hemoglobin level (p<0.05) in DM with malaria 
when compared with non-DM with malaria.
Conclusions: DM patients infected with plasmodium have low parasite density but higher hemoglobin 
level and PCV compared to the control group. There is no correlation between the severity of anemia 
and malaria parasitemia in DM patients infected with malaria when compared to non-diabetic subjects 
infected with malaria. Further studies are needed to explore the correlation between hemoglobin level 
in DM and plasmodium infection.
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wellbeing danger for quite a long time more 
than some other ailment, with 80% of malaria 
cases and mortality going on in Africa, affecting 
both young and old. Regardless of extra special 
development in medical sciences, malaria and 
DM continue to be a chief killer.7,8 Anemia is 
two times as common in DM in comparison 
with non-diabetic.9 Anemia is described as a 
condition where the hemoglobin (HGb) level 
is reduced, which diminishes the oxygen-
carrying limit of red blood cells to tissues. It is 
likewise a worldwide general health problem 
affecting both advanced and developing 
nations.9 Despite all these scientific shreds of 
evidence, anemia is not associated with about 
25% of diabetic patients. Moreover, the danger 
of anemia is better in people with diabetic 
nephropathy in comparison with individuals 
with nephropathy from other sources as this 
is associated with a greater speedy decline 
in the glomerular filtration rate (GFR). There 
is a significant correlation of anemia with 
exceptionally low serum erythropoietin in 
men and women with either type 1 or type 
2 diabetes, even without advanced kidney 
ailment or overt uremia.10 The etiology of 
anemia in diabetes is multi-factorial and 
these encompass nutritional deficiencies, 
concomitant autoimmune diseases, drugs, 
inflammation, and hormonal changes further 
to kidney disease.11 
Anemia and malaria parasitemia is endemic 
in developing nations among others in Nigeria. 
It is therefore important to diagnose malaria 
in DM patients and further determine the 
correlation between the degree of anemia 
and severity of malaria infection in DM to 
oversee it fittingly. Subsequently, this study is 
aimed to overcome any barrier in information 
and providing useful data to the medical and 
scientific community in the management of 
DM infected with Plasmodium falciparum.
 
Methods
This was a case-control study, performed 
between January to August 2019, including 
100 subjects from Owo Metropolis-Nigeria, 
comprised of DM patients infected with malaria 
(n50) and non-DM patients as a control group. 
Fasting plasma glucose levels greater than 
7.0 mmo/l on two or more occasions were 
designated as DM.3 The control was further 
regrouped as non-DM patients infected with 
malaria (n25) and non-DM without malaria 
parasitemia (n25). All the participants were 
aged between 30–70 years old. The medical 
and personal information had been obtained 
via a comprehensive questionnaire. Exclusion 
criteria were diabetic patients with medical 
complications, including hypertension, human 
immunodeficiency virus (HIV), hepatitis, and 
cancer. Pregnant and breastfeeding mothers 
were also excluded from the study. Participants 
in this study had been fully briefed on the study 
protocols inside the health facility and then 
they were required to sign a written consent. 
Ethical approval with registration number 
FMC/OW/380/VOL.LXX/66 was obtained 
from the Ethical Review Committee, Federal 
Medical Centre, Owo-Nigeria.
Six milliliters (6 ml) of venous blood 
was aseptically collected from the median-
cubital vein after 12 hours of fasting. Three 
milliliters (3 ml) of collected venous blood 
was dispensed into a fluoride oxalate bottle, 
gently mixed, and thereafter used for the 
determination of fasting blood sugar to 
confirm diabetic condition. Blood levels of 
fasting blood sugar were estimated using the 
standard spectrophotometric technique.12 The 
remaining 3 ml of venous blood was dispensed 
into an ethylene diamine tetra-acetic acid 
(EDTA) bottle for determination of packed cell 
volume (PCV), hemoglobin concentration, and 
malaria parasitemia. 
The packed cell volume (PCV) and 
hemoglobin concentration were determined 
by the manual method as described by 
Cheesbrough.12 The malaria parasite density 
test was determined from Giemsa stained 
peripheral blood smear.12 The level of 
parasitemia was in a microliter (ul) of blood 
thick film preparation, graded as low or + (1 
to 999/ul), moderate or ++ (1000 to 9999/
ul) and severe or +++ (> 10,000/ul), based on 
WHO criteria13 and Al-Salahy et al.14
Malaria parasite density was estimated by 
counting parasites against white blood cells. 
The number of parasites per microliter was 
calculated as follows.
One way analysis of variance (ANOVA) 
was used for comparison within the groups. 
A correlation was used to test the association 
between variables among DM with malaria. 
Data were presented using mean±standard 
deviation (mean±SD) for all quantitative 
values. The level of significance was taken as a 
95% confidence interval and p values less than 
or equal to 0.05 were considered significant. 
A statistical package for social sciences (SPSS) 
v.23.0 was used for the analysis of the data.
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Age (Years) 50.9±17.48 a,b 39.12±11.35 c 39.40±10.33 c
HGb (g/dl) 12.43±1.59 a 10.74±1.68 b,c 13.64±1.16 a,c
PCV (%) 35.67±6.84 a,b 32.12±5.04 b,c 40.78±3.39 a,c
Note: * significant at p≤0.05, a = significantly different from non-DM  with malaria; b = significantly different from non-
DM without malaria; c = significantly different from DM with malaria, HGb= Hemoglobin, PCV= Packed cell volume
Results
The mean age among respondents was as 
followed: DM with malaria was 50.9 years old 
±17.48, non-DM with malaria 39.12 years old 
±11.35, and non-DM without malaria 39.40 
years old ±10.33, respectively. The Hb and 
PCV values were compared between groups as 
shown in Table 1. There was a lower significant 
value of PCV and hemoglobin in DM with 
malaria when compared with non-DM without 
malaria. Furthermore, there was statistically 
significant higher hemoglobin and PCV in 
diabetic subjects with malaria than non-DM 
patients with malaria (p<0.05).
In Figure 1, there was a statistically 
significant higher blood glucose concentration 
in diabetic subjects when compared with non-
diabetics with and without malaria. Figure 
2 shows that the mean parasite density in 
diabetic subjects with malaria was significantly 
lower than in the non-diabetic group with 
malaria. Figures 3 and 4 show the correlation 
between malaria parasite densities and 
packed cell volume (p=0.844, r=0.029) and 
hemoglobin (p=0.952, r=-0.009) respectively, 
and no statistically significant correlation was 
observed.
Discussion
The association of malaria with either 
hyperglycemia or hypoglycemia has been 
documented in several studies since there 
is a dependency of malaria parasites on an 
exogenous supply of glucose for survival due 
Figure 1 Fasting Blood Glucose (FBG) among DM with Malaria, Non-DM with Malaria, and 
    Non-DM without Malaria
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to the inability to store calories in form of 
glycogen.2,15 Diabetes and malaria are common 
in developing countries with high fatalities 
and are thus major public health problems.15
Approximately 216 million cases of 
Plasmodium falciparum malaria has been 
documented in 2016 and induced an estimated 
445,000 deaths, frequently among children 
residing in sub-Saharan Africa.1,11 Malaria is 
one of the major causes of anemia in endemic 
areas, which is one of the inceptive factors 
for blood transfusion in those regions. The 
Figure 2 Malaria Parasite Density among DM and non-DM Patients with Malaria
Figure 3 Correlation between Malaria Parasite Density and Packed Cell Volume in Diabetic 
     Patients with Malaria 
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majority of fatalities attributed to malaria 
have occurred directly or indirectly from 
anemia.11 Additionally, anemia, an index of 
malnutrition, is common in Plasmodium 
falciparum infection and has been reported 
aggravating its complications.16-17 The result 
of this study revealed a significantly lower 
malaria parasite density count in diabetic 
subjects when compared with control subjects 
with malaria parasitemia. This is in accordance 
with a study which revealed a higher parasite 
density in non-diabetic subjects when 
compared with diabetic patients,18 but other 
study contradicted the result that reported the 
possibility of high malaria infection in diabetic 
patients.19 
Interestingly, there was a significantly 
higher (p<0.05) PCV and hemoglobin in DM 
with malaria when compared with non-
diabetics without malaria. This corroborates 
earlier reports that malaria is one of the leading 
causes of anemia.11 Even though DM has been 
documented as a diverse group of metabolic 
disorders that are often related to an excessive 
disease burden in developing countries such 
as Nigeria3, anemia has not been reported as 
one of its symptoms. In this study, there is no 
statistically significant correlation between 
malaria parasite densities, packed cell volume, 
and hemoglobin in DM patients with malaria 
parasitemia. In P. falciparum malaria, there may 
be sequestration of red blood cells containing 
mature parasites in the microcirculation.11 
This simply means the density of the malaria 
parasite is corresponding to the severity of 
anemia. Possibly, this is correlated with higher 
hemoglobin and PCV in DM with malaria in 
comparison with non-DM with malaria that 
we found in this study. 
Another factor that contributes to reduce 
the anemia rate among DM patients infected 
with plasmodium infection is the anti-malarial 
property of the glucose-lowering drug 
metformin taken by DM patients. Metformin is 
the most broadly used oral glucose-lowering 
drugs and it has been recognized for its anti-
malarial properties.20 In a massive study done 
in Ghana, metformin used for DM has been 
discovered to have an appreciably decrease 
incidence of malaria compared to those 
without.20 With the anti-malarial property of 
this drug, there is a reduced level of red cells 
that are parasitized. For this reason, few red 
cells are hemolysed and a reduction in the 
severity of anemia in diabetes is therefore 
observed.15,20 
One of the limitations of this work is that 
we could not ascertain the anti-malarial 
properties of metformin. Therefore, similarly, 
studies need to be executed to assess the anti-
malaria properties of anti-diabetic drugs with 
a larger sample size. 
In conclusion, low parasite density, high 
hemoglobin, and PCV are present in DM 
Figure 4 Correlation between Malaria Parasite Density and Hemoglobin in Diabetic Patients 
    with Malaria 
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patients infected with plasmodium. Hence, 
there is no correlation between the severity 
of anemia and malaria parasitemia in DM 
patients with parasitemia. Further study is 
needed to explore the anti-malarial properties 
of metformin. 
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